In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer

被引:49
作者
Fiumara, A
Belfiore, A
Russo, G
Salomone, E
Santonocito, GM
Ippolito, O
Vigneri, R
Gangemi, P
机构
[1] UNIV CATANIA, IST MED INTERNA & MALATTIE ENDOCRINE & METAB, CATTEDRA ENDOCRINOL, I-95123 CATANIA, ITALY
[2] UNIV CATANIA, PRESIDIO OSPED VITTORIO EMANUELE II, SERV ANAT & ISTOL PATOL, I-95123 CATANIA, ITALY
[3] UNIV CATANIA, CATTEDRA CHIRURG, I-95123 CATANIA, ITALY
关键词
D O I
10.1210/jc.82.5.1615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated the occurrence, tissue distribution, and prognostic Value of tumor-associated macrophages in 121 papillary thyroid carcinomas using immunohistochemical staining with anti-CD68 antibody in archival paraffin-embedded sections. Lymphocytic infiltration and dendritic cell presence were also evaluated. Three groups were identified according to the presence and characteristics of macrophages: 1) tumors without evidence of infiltrating macrophages: (n = 35); 2) tumors with infiltrating macrophages but no evidence of neoplastic cells phagocytosis (n = 68); and 3) tumors with infiltrating macrophages and in situ evidence of active neoplastic cell phagocytosis (n = 18). Neoplastic cell phagocytosis by macrophages was positively correlated with both lymphocytic infiltration and dendritic cells (P = 0.0000), whereas it was negatively correlated with vascular invasion (P = 0.0032). Distant metastases developed in none of the 18 tumors with neoplastic cell phagocytosis, but occurred in 15 of 103 of the remaining tumors (P = 0.0647) and were significantly and negatively associated with lymphocytic infiltration or dendritic cells. The present study indicates, therefore, that immune reaction, involving neoplastic cell phagocytosis by macrophages and lymphocytic infiltration, plays a role in the development of distant metastases in patients with papillary thyroid cancer.
引用
收藏
页码:1615 / 1620
页数:6
相关论文
共 30 条
  • [1] ALLEN CA, 1987, CANCER RES, V47, P2919
  • [2] [Anonymous], ENDOCRINE TUMORS
  • [3] THE IMMUNE-RESPONSE TO PAPILLARY THYROID-CANCER
    BAKER, JR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) : 3419 - 3420
  • [4] INCREASED AGGRESSIVENESS OF THYROID-CANCER IN PATIENTS WITH GRAVES-DISEASE
    BELFIORE, A
    GAROFALO, MR
    GIUFFRIDA, D
    RUNELLO, F
    FILETTI, S
    FIUMARA, A
    IPPOLITO, O
    VIGNERI, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) : 830 - 835
  • [5] DENOVO HLA CLASS-II AND ENHANCED HLA CLASS-I MOLECULE EXPRESSION IN SV40 TRANSFECTED HUMAN THYROID EPITHELIAL-CELLS
    BELFIORE, A
    MAUERHOFF, T
    PUJOLBORRELL, R
    BADENHOOP, K
    BUSCEMA, M
    MIRAKIAN, R
    BOTTAZZO, GF
    [J]. JOURNAL OF AUTOIMMUNITY, 1991, 4 (03) : 397 - 414
  • [6] BISI H, 1989, CANCER, V64, P1888, DOI 10.1002/1097-0142(19891101)64:9<1888::AID-CNCR2820640922>3.0.CO
  • [7] 2-C
  • [8] The immunology of thyroid cancer
    Boyd, CM
    Baker, JR
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (01) : 159 - +
  • [9] CLAASEN HHV, 1992, LAB INVEST, V67, P166
  • [10] COX DR, 1972, J R STAT SOC B, V34, P187